Kyoto University: Granted iPS cell license to Avery: Cardiomyocyte manufacturing method

Genetics, , disease, IPS, Medical science

COVID-19: Osaka University artificially synthesizes mutant virus: shortened to 2 weeks

Vaccine, , Medical science, Pharmaceutical

COVID-19: Chinese vaccine, suggesting low efficacy: CCDC / Gao Fu

Vaccine, flu, , , Pharmaceutical

Kyoto University: Making placental cells from iPS: Human naive iPS cells

disease, IPS, Medical science

COVID-19: Kyoto University discovers new corona drug candidate: raloxifene and pioglitazone

flu, , Drugs, IPS, Pharmaceutical

Posts navigation